Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes

Review proposal consultation

Stakeholder matrix (PDF 261 KB)

Review proposal paper (PDF 321 KB)

Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): final appraisal determination information

Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): final appraisal document (PDF 448 KB)

Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): evaluation report information

Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): evaluation report (PDF 1.14 MB)

Acute coronary syndrome - prasugrel with PCI (review TA182): Appraisal consultation

Acute coronary syndrome - prasugrel with PCI (review TA182): Appraisal consultation document information

Acute coronary syndrome - prasugrel with PCI (review TA182): Evaluation report information

Acute coronary syndrome - prasugrel with PCI (review TA182): Evaluation report (PDF 7.15 MB)

Acute coronary syndrome - prasugrel with PCI (review TA182): equality impact assessment - guidance development (PDF 236 KB)

Acute coronary syndrome - prasugrel with PCI (review TA182): assessment report (PDF 2.89 MB)

Acute coronary syndrome - prasugrel with PCI (review TA182): final protocol (PDF 552 KB)

Acute coronary syndrome - prasugrel with PCI (review TA182): EIA - Scoping (PDF 65 KB)

Acute coronary syndrome - prasugrel with PCI (review TA182): final scope (PDF 100 KB)

Acute coronary syndrome - prasugrel with PCI (review TA182): final matrix (PDF 103 KB)

Acute coronary syndrome - prasugrel with PCI (review TA182): provisional matrix (PDF 106 KB)

Acute coronary syndrome - prasugrel with PCI (review TA182): draft scope (PDF 101 KB)